VMD Viemed Healthcare Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: VMD

Price (delayed)

$8.18

Market cap

$317.03M

P/E Ratio

30.3

Dividend/share

N/A

EPS

$0.27

Enterprise value

$314.51M

Viemed Healthcare Inc. is a provider of in-home medical equipment and post-acute respiratory healthcare services in the United States. Viemed's service offerings are focused on effective in-home treatment with clinical ...

Highlights
Viemed Healthcare's EPS has surged by 69% YoY and by 13% QoQ
The net income has surged by 65% year-on-year and by 11% since the previous quarter
VMD's quick ratio is down by 43% year-on-year but it is up by 9% since the previous quarter
The price to earnings (P/E) is 30% lower than the last 4 quarters average of 43.2 but 11% higher than the 5-year quarterly average of 27.3
Sector: Healthcare
Industry: Medical Devices
Website: http://www.viemed.com
Peers: PNTG OPCH MODV

Key stats

What are the main financial stats of VMD
Market
Shares outstanding
38.76M
Market cap
$317.03M
Enterprise value
$314.51M
Valuations
Price to earnings (P/E)
30.3
Price to book (P/B)
2.76
Price to sales (P/S)
1.71
EV/EBIT
21.23
EV/EBITDA
8.58
EV/Sales
1.72
Earnings
Revenue
$183.01M
EBIT
$14.82M
EBITDA
$36.68M
Free cash flow
$21.71M
Per share
EPS
$0.27
Free cash flow per share
$0.57
Book value per share
$2.96
Revenue per share
$4.77
TBVPS
$3.25
Balance sheet
Total assets
$154.9M
Total liabilities
$41M
Debt
$10.32M
Equity
$113.9M
Working capital
$6.24M
Liquidity
Debt to equity
0.09
Current ratio
1.19
Quick ratio
0.97
Net debt/EBITDA
-0.07
Margins
EBITDA margin
20%
Gross margin
61.6%
Net margin
5.6%
Operating margin
7.8%
Efficiency
Return on assets
7.1%
Return on equity
9.6%
Return on invested capital
16.9%
Return on capital employed
12.1%
Return on sales
8.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

VMD stock price

How has the Viemed Healthcare stock price performed over time
Intraday
-0.12%
1 week
-1.56%
1 month
-8.6%
1 year
-23.55%
YTD
4.2%
QTD
-13.26%

Financial performance

How have Viemed Healthcare's revenue and profit performed over time
Revenue
$183.01M
Gross profit
$112.78M
Operating income
$14.33M
Net income
$10.24M
Gross margin
61.6%
Net margin
5.6%
The operating income has soared by 74% YoY and by 14% from the previous quarter
The net income has surged by 65% year-on-year and by 11% since the previous quarter
VMD's gross profit is up by 33% YoY and by 9% QoQ
The operating margin is up by 32% year-on-year and by 5% since the previous quarter

Growth

What is Viemed Healthcare's growth rate over time

Valuation

What is Viemed Healthcare stock price valuation
P/E
30.3
P/B
2.76
P/S
1.71
EV/EBIT
21.23
EV/EBITDA
8.58
EV/Sales
1.72
Viemed Healthcare's EPS has surged by 69% YoY and by 13% QoQ
The price to earnings (P/E) is 30% lower than the last 4 quarters average of 43.2 but 11% higher than the 5-year quarterly average of 27.3
The equity is up by 17% year-on-year and by 4.7% since the previous quarter
The P/B is 16% lower than the 5-year quarterly average of 3.3 and 11% lower than the last 4 quarters average of 3.1
The revenue has grown by 32% year-on-year and by 8% since the previous quarter
The P/S is 26% below the 5-year quarterly average of 2.3 and 15% below the last 4 quarters average of 2.0

Efficiency

How efficient is Viemed Healthcare business performance
The company's return on invested capital has surged by 51% YoY and by 10% QoQ
The ROE has soared by 50% YoY and by 7% from the previous quarter
The ROA is up by 34% YoY and by 4.4% QoQ
Viemed Healthcare's return on sales has increased by 23% YoY and by 5% QoQ

Dividends

What is VMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VMD.

Financial health

How did Viemed Healthcare financials performed over time
The total liabilities has soared by 106% year-on-year
VMD's current ratio is down by 44% YoY but it is up by 4.4% from the previous quarter
The company's debt is 91% lower than its equity
The equity is up by 17% year-on-year and by 4.7% since the previous quarter
Viemed Healthcare's debt to equity has decreased by 10% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.